Overview Fundamentals API Earnings EOD API Sample Code Pricing

NKGen Biotech Inc. Common Stock (NKGN NASDAQ) stock market data APIs

$0.898 -0.04(-4.3%) as of July 17, 2024
Price chart is built with Anychart

NKGen Biotech, Inc. operates as a clinical-stage biotechnology company that focuses on the development and commercialization of autologous, allogeneic, and CAR-NK natural killer cell therapies. Its lead products include SNK01, an autologous NK cell therapy candidate treatment for neurodegenerative diseases; and SNK02, an allogeneic NK cell therapy, which is in Phase 1 clinical trials for refractory solid tumors. The company has a license agreement with NKMAX. The company was formerly known as NKMAX America, Inc. NKGen Biotech, Inc. was founded in 2017 and is headquartered in Santa Ana, California. NKGen Biotech, Inc. operates as a subsidiary of NKMAX Co., Ltd.

NKGen Biotech Inc. Common Stock Financial Data Overview

49 408 K
21 889 K
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'NKGN',
Type: 'Common Stock',
Name: 'NKGen Biotech Inc. Common Stock',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00ZFCTT22',
CIK: '1845459',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2021-07-13',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,

NKGen Biotech Inc. Common Stock Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -25 365 000
  • Earnings Per Share -2.57
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get NKGen Biotech Inc. Common Stock Earnings via APIs

  • Latest Release 2024-03-31
  • EPS/Forecast NaN

Get NKGen Biotech Inc. Common Stock End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?